Copyright
©The Author(s) 2020.
World J Gastroenterol. Jan 14, 2020; 26(2): 168-183
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.168
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.168
Figure 1 Serum expression levels of lncRNAs and mRNA in healthy controls, hepatitis C virus naïve patients and hepatitis C virus treated patients with different treatment regimens.
A: LncRNA GAS5; B: LncRNA BISPR; C: LncRNA HEIH; D: mRNA BST2. bP < 0.01, vs control group; dP < 0.01, vs naïve group; Data were analyzed by On e-way ANOVA test followed by Tukey HSD multiple comparison test.
- Citation: El Samaloty NM, Shabayek MI, Ghait RS, El-Maraghy SA, Rizk SM, El-Sawalhi MM. Assessment of lncRNA GAS5, lncRNA HEIH, lncRNA BISPR and its mRNA BST2 as serum innovative non-invasive biomarkers: Recent insights into Egyptian patients with hepatitis C virus type 4. World J Gastroenterol 2020; 26(2): 168-183
- URL: https://www.wjgnet.com/1007-9327/full/v26/i2/168.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i2.168